Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(12):939-941; doi:10.1093/jnci/dji160
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Schiffman, M.
Right arrow Articles by Wheeler, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Schiffman, M.
Right arrow Articles by Wheeler, C.
Related Collections
Right arrowRelated Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

CORRESPONDENCE

RESPONSE: Re: A Study of the Impact of Adding HPV Types to Cervical Cancer Screening and Triage Tests

Mark Schiffman, Philip E. Castle, Diane Solomon, Mark Stoler, Cosette Wheeler

Affiliations of authors: National Cancer Institute, National Institutes of Health, U.S. Departments of Health and Human Service, Bethesda, MD (MS, PEC, DS); Department of Pathology, University of Virginia, Charlottesville, VA (MS); Departments of Molecular Genetics and Microbiology and Obstetrics and Gynecology, University of New Mexico, Albuquerque, NM (CMW)

Correspondence to: Mark Schiffman, MD, MPH, Hormonal and Reproductive Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD (e-mail: schiffmm@exchange.nih.gov).

The first 10% of the full text of this article appears below.

The use of human papillomavirus (HPV) DNA testing for triage of atypical squamous cells (ASCs or equivocal cytologic specimens) is already widespread, and its promise for general screening is gaining acceptance (1). The value of impending widespread HPV testing will depend on how thoughtfully it is used.

As supported by Franceschi and Clifford's statistically powerful contribution, epidemiologists are reaching agreement concerning . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Correspondence

Re: A Study of the Impact of Adding HPV Types to Cervical Cancer Screening and Triage Tests
Silvia Franceschi and Gary M. Clifford
J Natl Cancer Inst 2005 97: 938-939. [Extract] [Full Text] [PDF]